Announcements Trials
Browse Landscape

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Hyperandrogenism 1

Interventions

Metformin 8Progesterone 6Spironolactone 4drospirenone and ethinyl estradiol combination 3Inositol 3Ethinyl Estradiol 3salicylsalicylic acid 2Sugars 2Folic Acid 2Flutamide 2Estradiol 2Cyproterone Acetate 2Clomiphene 2maltodextrin 1licogliflozin 1bicalutamide 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Ultrasonography 1Topiramate 1Time 1Thioctic Acid 1Sodium Salicylate 1Sex Characteristics 1Physical Examination 1Phlebotomy 1Phenotype 1Ovidrel 1Magnesium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperandrogenism × Phenotype × Clear all
NCT02611128 2023-11-02

DENND1A

University of Virginia

Suspended
65 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡